Glenmark Pharmaceuticals Ltd
NSE: GLENMARK BSE: 532296
₹2136.70
(0.58%)
Mon, 09 Mar 2026, 02:10 pm
Market Cap603.26B
PE Ratio56.64
Dividend0.23
Glenmark Pharmaceuticals Cashflow
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deprecation and amortization | -241.71M | -442.59M | -724.71M | -1.03B | -1.21B | -946.78M | -978.78M | -1.27B | -2.17B | -2.60B | -2.64B | -5.77B | -3.54B | -3.26B | -4.17B | -4.44B | -4.87B | -5.69B | -5.82B | -4.86B |
| Accumulated depreciation, total | -506.39M | -728.29M | -1.22B | -1.35B | -1.88B | -2.15B | -2.98B | -3.77B | -4.75B | -5.62B | -6.61B | -7.87B | -9.38B | -10.98B | -13.81B | -16.68B | -17.65B | -19.42B | -20.98B | -23.92B |
| Cash from operating activities | -413.82M | 552.06M | 3.09B | -1.23B | 1.88B | 7.89B | 6.48B | 5.07B | 6.66B | 3.05B | 1.73B | 4.93B | 14.45B | 10.58B | 10.96B | 8.41B | 8.68B | 3.37B | -7.65B | -9.76B |
| Funds from operations | 1.24B | 3.81B | 6.93B | 2.65B | 3.97B | 4.35B | 6.83B | 7.60B | 9.56B | 5.72B | 7.81B | 13.54B | 11.36B | 9.22B | 9.69B | 12.26B | 14.29B | 14.11B | 318.90M | 15.52B |
| Net income (cash flow) | 879.76M | 3.10B | 6.32B | 1.92B | 3.24B | 4.53B | 4.60B | 6.15B | 5.42B | 4.75B | 7.02B | 9.16B | 7.74B | 9.25B | 7.76B | 9.70B | 9.42B | 2.97B | -15.02B | 10.47B |
| Depreciation & amortization (cash flow) | 235.79M | 438.70M | 716.79M | 1.03B | 1.21B | 946.78M | 978.28M | 1.27B | 2.17B | 2.60B | 2.64B | 5.77B | 3.54B | 3.26B | 4.17B | 4.44B | 4.87B | 6.11B | 6.31B | 4.86B |
| Depreciation/depletion | 143.31M | 248.69M | 325.24M | 495.89M | 576.32M | 725.65M | 781.73M | 867.32M | 1.07B | 1.16B | 1.22B | 1.43B | 1.57B | 1.81B | 2.71B | 3.16B | — | 3.81B | — | 3.59B |
| Amortization | 92.49M | 190.01M | 391.55M | 530.94M | 629.79M | 221.13M | 196.55M | 402.77M | 1.10B | 1.44B | 1.41B | 4.33B | 1.97B | 3.65B | 1.46B | 1.27B | — | 2.30B | — | 1.27B |
| Deferred taxes (cash flow) | — | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | -79.79M | -197.38M | -812.05M | -987.12M | -1.08B | -1.41B | 967.57M | -1.00B | 425.18M | -2.82B | -4.87B | -4.82B | -2.85B | -7.05B | -5.44B | -6.00B | -4.99B | 5.60B | -6.35B | -3.33B |
| Changes in working capital | -1.66B | -3.26B | -3.85B | -3.88B | -2.09B | 3.53B | -347.93M | -2.53B | -2.90B | -2.67B | -6.08B | -8.62B | 3.09B | 1.36B | 1.27B | -3.86B | -5.61B | -10.74B | -7.97B | -25.29B |
| Cash from investing activities | -2.60B | -2.70B | -5.18B | -9.55B | -3.88B | -3.71B | -2.84B | -4.68B | -3.75B | -5.83B | -8.89B | -7.33B | -10.23B | -6.27B | -7.71B | -6.78B | -3.43B | -5.52B | 45.44B | -400.30M |
| Capital expenditures | -2.62B | -2.80B | -5.23B | -9.74B | -3.96B | -4.01B | -2.85B | -4.71B | -3.77B | -5.44B | -8.90B | -7.49B | -10.45B | -12.37B | -9.31B | -7.75B | -7.90B | -6.08B | -9.15B | -7.51B |
| Capital expenditures - fixed assets | -2.62B | -2.80B | -5.23B | -9.74B | -3.96B | -4.01B | -2.85B | -4.71B | -3.77B | -5.44B | -8.90B | -7.49B | -10.45B | -12.37B | -9.31B | -7.75B | -7.90B | -6.08B | -8.98B | -7.50B |
| Capital expenditures - other assets | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | 0 | 0 | 0 | — | — | -165.03M | -11.51M |
| Cash from financing activities | 2.80B | 2.15B | 2.60B | 9.93B | 2.36B | -2.90B | -1.98B | 3.42B | 962.50M | 4.19B | 8.79B | 7.27B | -2.55B | -4.69B | -1.43B | -1.48B | -2.70B | 2.34B | -33.89B | 9.78B |
| Free cash flow | -3.04B | -2.24B | -2.14B | -10.97B | -2.08B | 3.87B | 3.62B | 363.06M | 2.89B | -2.39B | -7.17B | -2.56B | 4.00B | -1.79B | 1.65B | 658.30M | 776.93M | -2.71B | -16.63B | -17.26B |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800